<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="50199">Pefloxacin</z:chebi> (Abaktal) efficacy and safety were investigated at 21 children (7-16 years old) randomized in 2 groups: children with <z:e sem="disease" ids="C0010674" disease_type="Disease or Syndrome" abbrv="">mucoviscidosis</z:e> and children with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The drug was used at the dose 15-20 mg/kg per day bid for 14-28 days </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="50199">Pefloxacin</z:chebi> was used in combination with <z:chebi fb="0" ids="3508">ceftazidime</z:chebi> and <z:chebi fb="0" ids="2637">amikacin</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Combined therapy demonstrated good clinical efficacy </plain></SENT>
<SENT sid="4" pm="."><plain>Bacteriological efficacy was not uniform: staphylococci were not isolated from sputum since the 7th day of treatment, but pseudomonads were cultured even on the 14th day of the treatment (the sensitivity to <z:chebi fb="0" ids="50199">pefloxacin</z:chebi> remained) </plain></SENT>
<SENT sid="5" pm="."><plain>The only but frequent side-effect was <z:hpo ids='HP_0003040'>arthropathy</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>The background and some peculiarities of <z:hpo ids='HP_0003040'>arthropathy</z:hpo> development were analyzed </plain></SENT>
<SENT sid="7" pm="."><plain>This phenomenon is called <z:chebi fb="1" ids="23765">quinolone</z:chebi>-induced <z:hpo ids='HP_0100769'>synovitis</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>The risk group for <z:chebi fb="1" ids="23765">quinolone</z:chebi>-induced <z:hpo ids='HP_0100769'>synovitis</z:hpo> was estimated--children elder than 10 years with allergic anamnesis </plain></SENT>
<SENT sid="9" pm="."><plain>Good clinical efficacy and tolerability of <z:chebi fb="0" ids="50199">pefloxacin</z:chebi> at the children with <z:e sem="disease" ids="C0010674" disease_type="Disease or Syndrome" abbrv="">mucoviscidosis</z:e> or <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> is a reason and base to cancel the limits to its use in pediatrics </plain></SENT>
</text></document>